Buy SLS by May 4, 2026.

New to investing and trading and, although biotech stocks have a bad reputation, these three stand out. Great results, good leadership and some approvals already. They all have many scheduled catalysts and- in SLS- maybe an early end to a trial that seems to be a huge success. I'm playing with 10,000 as a newbie separate from my boring retirement fund so I'm investing in all three. Planning to move the money around as different catalysts come but I'd hate …